New shot offers hope for teens battling severe, itchy skin
NCT ID NCT07309055
Summary
This study is testing an investigational injection called SHR-1819 to see if it can safely reduce the severe skin rash and intense itching of eczema in teenagers. About 200 teens, aged 12-17, whose eczema hasn't improved enough with standard creams will receive either the real injection or a placebo (dummy shot) for comparison. The main goal is to see if the treatment can clear or almost clear the skin and significantly reduce itch over 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, 110002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.